Prevention of Vitamin K deficiency bleeding in newborn infants: A position paper by the ESPGHAN committee on nutrition

Journal of Pediatric Gastroenterology and Nutrition

Volumn 63, Issue 1, 2016, Pages 123-129

  Mihatsch, Walter A ^a   Braegger, Christian ^b   Bronsky, Jiri ^c   Campoy, Cristina ^d   Domellöf, Magnus ^e   Fewtrell, Mary ^f   Mis, Nataša F ^g   Hojsak, Iva ^h   Hulst, Jessie ⁱ   Indrio, Flavia ^j   Lapillonne, Alexandre ^k,l   Molgaard, Christian ^m,n   Embleton, Nicholas ^o   Van Goudoever, Johannes ^p,q  

^a Clinic of Psychosomatic Medicine and Psychotherapy   (Germany)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d UNIVERSITY OF GRANADA   (Spain)

^e UMEÅ UNIVERSITY   (Sweden)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^h Alergologiju I Reumatologiju S Klini kom Imunologijom   (Croatia)

ⁱ SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^j UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^k HÔPITAL NECKER ENFANTS MALADES   (France)

^l BAYLOR COLLEGE OF MEDICINE   (United States)

^m UNIVERSITY OF COPENHAGEN   (Denmark)

ⁿ ODENSE UNIVERSITY HOSPITAL   (Denmark)

^o NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^p VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^q EMMA CHILDREN S HOSPITAL   (Netherlands)

more..

Author keywords

newborn infant; Vitamin K; Vitamin K deficiency bleeding

Indexed keywords

MENADIONE; MENAQUINONE; PHYTOMENADIONE; VITAMIN K GROUP;

ARTICLE; BIOAVAILABILITY; CHILDBIRTH EDUCATION; CHILDHOOD DISEASE; CHOLESTASIS; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DRUG BIOAVAILABILITY; DRUG SAFETY; HEALTH CARE PERSONNEL; HIGH RISK INFANT; HISTORY OF MEDICINE; HUMAN; INFANT; MALABSORPTION; NEWBORN; NEWBORN HEMORRHAGIC DISEASE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; VITAMIN K DEFICIENCY; VITAMIN K METABOLISM; DOSE RESPONSE; DRUG ADMINISTRATION; EUROPE; FEMALE; INFANT NUTRITION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MEDICAL SOCIETY;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EUROPE; FEMALE; HUMANS; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; INJECTIONS, INTRAMUSCULAR; MALE; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; VITAMIN K; VITAMIN K DEFICIENCY BLEEDING;

EID: 84962343512     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001232     Document Type: Article

References (98)

1. McNinch A. Vitamin K deficiency bleeding: early history and recent trends in the United Kingdom. Early Hum Dev 2010; 86(suppl 1): 63-5.
2. Townsend CW. The haemorrhagic disease of the newborn. Arch Paediatr 1994; 11: 652-3.
3. American Academy of Pediatrics. Controversies concerning vitamin K and the newborn. American Academy of Pediatrics Committee on Fetus and Newborn. Pediatrics 2003; 112: 191-2.
4. Smith CH. Blood Diseases of Infancy and Childhood. St. Louis: Mosby 1960
5. Aballi AJ, Lopez Banus V, De Lamerens S, et al. Coagulation studies in the newborn period; alterations of thromboplastin generation and effects of vitamin K in full-term and premature infants. AMA J Dis Child 1957; 94: 589-600.
6. Vietti TJ, Murphy TP, James JA, et al. Observations on the prophylactic use of vitamin K in the newborn infant. J Pediatr 1960; 56: 343-6.
7. Dam H, Schönheyder F, Tage-Hansen H. Cholesterolstoffwechsel in Hühnereiern und Hühnchen. Biochem Z 1929; 215: 475-92.
8. Brinkhous KM, Smith BK, Warner BW. Plasmaprotein level in normal infancy and hemorrhagic disease of the newborn. Am J Med Sci 1937; 193: 475-80.
9. Dam H, Schonheyder F, Tage-Hansen E. Studies on the mode of action of vitamin K. Biochem J 1936; 30: 1075-9.
10. Dam H, Dyggve H, Larsen H, et al. The relation of vitamin K deficiency to hemorrhagic disease of the newborn. Adv Pediatr 1952; 5: 129-53.
11. Dam H, Tage-Hansen E. Vitamin-K lack in normal and sick infants. Lancet 1939; 2: 1157-62.
12. Hellmann LM, Shettles LB. Factors influencing plasma prothrombin in the newborn infant I. Prematurity and vitamin K. Bull Hopkins Hosp 1939; 65: 138-41.
13. Owen A. Blood coagulation during infancy. Proc Soc Exp Biol Med 1939; 41: 181-8.
14. Shettles LB, Delfs E, Hellmann LM. Factors influencing plasma prothrombin in newborn infants. II. Antepartum and neonatal ingestion of vitamin K concentrate. Bull Hopkins Hosp 1939; 65: 419-26.
15. Quick AJ, Grossmann AM. The nature of the hemorrhagic disease of the newborn: delayed restoration of the prothormbin level. Am J Med Sci 1940; 199: 1-9.
16. Waddell WW, Guerry D, Bray WE, et al. Possible effects of vitamin K on prothrombin and clotting time in newly-born infants. J Path Bact 1937; 44: 633-5.
17. Almquist HJ, Close AA. Synthetic and natural antihemorrhagic compounds. Am J Chem Soc 1939; 61: 2557-8.
18. American Academy of Pediatrics. Report of the Committee on Nutrition: vitamin K compounds and the water-soluble analogues. Pediatrics 1961; 28: 501-6.
19. Shearer MJ. Vitamin K metabolism and nutriture. Blood Rev 1992; 6: 92-104.
20. McNinch AW, Orme RL, Tripp JH. Haemorrhagic disease of the newborn returns. Lancet 1983; 1: 1089-90.
21. American Academy of Pediatrics Vitamin K Ad Hoc Task Force. Controversies concerning vitamin K and the newborn. Pediatrics 1993; 91: 1001-3.
22. Bhanchet P, Tuchinda S, Hathirat P, et al A bleeding syndrome in infants due to acquired prothrombin complex deficiency: a survey of 93 affected infants. Clin Pediatr (Phila) 1977 16 992-8
23. Von Kries R, Hanawa Y. Neonatal vitamin K prophylaxis. Report of Scientific and Standardization Subcommittee on Perinatal Haemostasis. Thromb Haemost 1993; 69: 293-5.
24. Chardot C. Biliary atresia. Orphanet J Rare Dis 2006; 1: 28.
25. Evans AR, Forrester RM, Discombe C. Neonatal haemorrhage following maternal anticonvulsant therapy. Lancet 1970; 1: 517-8.
26. Laosombat V. Hemorrhagic disease of the newborn after maternal anticonvulsant therapy: a case report and literature review. J Med Assoc Thai 1988; 71: 643-8.
27. Hey E. Effect of maternal anticonvulsant treatment on neonatal blood coagulation. Arch Dis Child Fetal Neonatal Ed 1999; 81: F208-10.
28. Deblay MF, Vert P, Andre M, et al. Transplacental vitamin K prevents haemorrhagic disease of infant of epileptic mother. Lancet 1982; 1: 1247.
29. Rezvani M, Koren G. Does vitamin K prophylaxis prevent bleeding in neonates exposed to enzyme-inducing antiepileptic drugs in utero?. Can Fam Physician 2006; 52: 721-2.
30. F.A.O., WHO. Vitamin K. In: Nantel G, Tontisirin K, eds. Human Mineral and Vitamin Requirements. Rome: Food and Nutrition Division FAO 2001: 133-50 2001 133-50.
31. Suttie JW. The importance of menaquinones in human nutrition. Annu Rev Nutr 1995; 15: 399-417.
32. Usui Y, Tanimura H, Nishimura N, et al. Vitamin K concentrations in the plasma and liver of surgical patients. Am J Clin Nutr 1990; 51: 846-52.
33. Shearer MJ, McCarthy PT, Crampton OE, et al. The assessment of human vitamin K status from tissue measurements. In: Suttie JW, ed. Current Advances in Vitamin K Research. New York: Elsevier 1988 437-52.
34. Kayata S, Kindberg C, Greer FR, et al. Vitamin K1 and K2 in infant human liver. J Pediatr Gastroenterol Nutr 1989; 8: 304-7.
35. Shirahata A, Nakamura T, Ariyoshi N. Vitamin K1 and K2 in contents in blood, stool, and liver tissues of neonates and young infants. In: Suzuki S, Hathaway WE, Bonnar J, Sutor AH, eds. Perinatal Thrombosis and Hemostasis. Tokyo: Springer-Verlag 213-223
36. Kumar D, Greer FR, Super DM, et al. Vitamin K status of premature infants: implications for current recommendations. Pediatrics 2001; 108: 1117-22.
37. Greer FR, Marshall SP, Severson RR, et al. A new mixed micellar preparation for oral vitamin K prophylaxis: randomised controlled comparison with an intramuscular formulation in breast fed infants. Arch Dis Child 1998; 79: 300-5.
38. Lane PA, Hathaway WE. Vitamin K in infancy. J Pediatr 1985; 106: 351-9.
39. Sutor AH, von Kries R, Cornelissen EA, et al. Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric/Perinatal Subcommittee. International Society on Thrombosis and Haemostasis. Thromb Haemost 1999; 81: 456-61.
40. Choo KE, Tan KK, Chuah SP, et al. Haemorrhagic disease in newborn and older infants: a study in hospitalized children in Kelantan, Malaysia. Ann Trop Paediatr 1994; 14: 231-7.
41. Shearer MJ. Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Rev 2009; 23: 49-59.
42. McNinch AW, Tripp JH. Haemorrhagic disease of the newborn in the British Isles: two year prospective study. BMJ 1991; 303: 1105-9.
43. Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol 1993; 168: 884-8.
44. Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy. Am J Obstet Gynecol 1993; 168: 923-8.
45. Mountain KR, Hirsh J, Gallus AS. Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet 1970; 1: 265-8.
46. Thorp JA, Parriott J, Ferrette-Smith D, et al. Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: a randomized, double-blind, placebo-controlled trial. Obstet Gynecol 1994; 83: 70-6.
47. Von Kries R. Vitamin K prophylaxis-A useful public health measure?. Paediatr Perinat Epidemiol 1992; 6: 7-13.
48. Sutherland JM, Glueck HI, Gleser G. Hemorrhagic disease of the newborn. Breast feeding as a necessary factor in the pathogenesis. Am J Dis Child 1967; 113: 524-33.
49. Loughnan P, McDougall PM. The duration of vitamin K1 efficacy: is intramuscular vitamin K1 acting as a depot preparation?. In: Sutor AH, Hathaway WE, eds. Vitamin K in Infancy. Stuttgart, New York: Schattauer 1995
50. Sutor AH, Dagres N, Niederhoff H. Late form of vitamin K deficiency bleeding in Germany. Klin Padiatr 1995; 207: 89-97.
51. Hanawa Y, Maki M, Matsuyama E, et al. The third nationwide survey in Japan of vitaminKdeficiency in infancy. ActaPaediatr Jpn 1990; 32: 51-9.
52. Chaou WT, Chou ML, Eitzman DV. Intracranial hemorrhage and vitamin K deficiency in early infancy. J Pediatr 1984; 105: 880-4.
53. Pietersma-de Bruyn AL, Van Haard PM, Beunis MH, et al Vitamin K1 levels and coagulation factors in healthy term newborns till 4 weeks after birth. Haemostasis 1990 20 8-14.
54. Widdershoven J, LambertW, Motohara K, et al. Plasma concentrations of vitamin K1 and PIVKA-II in bottle-fed and breast-fed infants with and without vitamin K prophylaxis at birth. Eur J Pediatr 1988; 148: 139-42.
55. Haroon Y, Shearer MJ, Rahim S, et al. The content of phylloquinone (vitamin K1) in human milk, cows? milk and infant formula foods determined by high-performance liquid chromatography. J Nutr 1982; 112: 1105-17.
56. Russell R, Beard JL, Cousins R, et al. Vitamin K. In: IOM, ed. Institute of Medicine (US) Panel on Micronutrients. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press 162-196
57. Greer FR. Vitamin K status of lactating mothers and their infants. Acta Paediatr Suppl 1999; 88: 95-103.
58. Von Kries R, Kreppel S, Becker A, et al Acarboxyprothrombin concentration [corrected] after oral prophylactic vitamin K. Arch Dis Child 1987 62 938-40.
59. Von Kries R, Becker A, Göbel U. Vitamin K in the newborn: influence of nutritional factors on a carboxy-prothrombin detectability and factor II and VII clotting activity. Eur J Pediatr 1987; 146: 123-7.
60. Motohara K, Endo F, Matsuda I. Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns. Lancet 1985; 2: 242-4.
61. Sharma RK, Marwaha N, Kumar P, et al. Effect of oral water soluble vitamin K on PIVKA-II levels in newborns. Indian Pediatr 1995; 32: 863-7.
62. Ulusahin N, Arsan S, Ertogan F. Effects of oral and intramuscular vitamin K prophylaxis on PIVKA-II assay parameters in breastfed infants in Turkey. Turk J Pediatr 1996; 38: 295-300.
63. Von Kries R, Reifenhauser A, Göbel U, et al. Late onset haemorrhagic disease of newborn with temporary malabsorption of vitamin K1. Lancet 1985; 1: 1035.
64. Matsuda I, Nishiyama S, Motohara K, et al. Late neonatal vitamin K deficiency associated with subclinical liver dysfunction in human milkfed infants. J Pediatr 1989; 114: 602-5.
65. Golding J, Greenwood R, Birmingham K, et al. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ 1992; 305: 341-6.
66. Fear NT, Roman E, Ansell P, et al. Vitamin K and childhood cancer: a report from the United Kingdom Childhood Cancer Study. Br J Cancer 2003; 89: 1228-31.
67. Roman E, Fear NT, Ansell P, et al. Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies. Br J Cancer 2002; 86: 63-9.
68. Cornelissen M, Von Kries R, Loughnan P, et al. Prevention of vitamin K deficiency bleeding: efficacy of different multiple oral dose schedules of vitamin K. Eur J Pediatr 1997; 156: 126-30.
69. Flood VH, Galderisi FC, Lowas SR, et al. Hemorrhagic disease of the newborn despite vitamin K prophylaxis at birth. Pediatric Blood Cancer 2008; 50: 1075-7.
70. Sutor AH, KuenzerW. Time interval between vitamin K administration and effective hemostasis. In: Suzuki S, Hathaway WE, Bonnar J, Sutor AH, eds. Perinatal Thrombosis and Hemostasis. Tokyo: Springer Verlag 1991
71. McNinch A, Busfield A, Tripp J. Vitamin K deficiency bleeding in Great Britain and Ireland: British Paediatric Surveillance Unit Surveys, 1993-94 and 2001-02. Arch Dis Child 2007; 92: 759-66.
72. Darlow BA, Phillips AA, Dickson NP. New Zealand surveillance of neonatal vitamin K deficiency bleeding (VKDB): 1998-2008. J Paediatr Child Health 2011; 47: 460-4.
73. Busfield A, Samuel R, McNinch A, et al. Vitamin K deficiency bleeding after NICE guidance and withdrawal of Konakion Neonatal: British Paediatric Surveillance Unit study. Arch Dis Child 2013; 98: 41-7.
74. Ciantelli M, Bartalena L, Bernardini M, et al. Late vitamin K deficiency bleeding after intramuscular prophylaxis at birth: a case report. J Perinatol 2009; 29: 168-9.
75. Chuansumrit A, Isarangkura P, Hathirat P. Vitamin K deficiency bleeding in Thailand: a 32-year history. Southeast Asian J Trop Med Public Health 1998; 29: 649-54.
76. Von Kries R, Hachmeister A, Göbel U. Can 3 oral 2 mg doses of vitamin K effectively prevent late vitamin K deficiency bleeding?. Eur J Pediatr 1999; 158(suppl 3): S183-6.
77. Schubiger G, Berger TM, Weber R, et al., Swiss Paediatric Surveillance U. Prevention of vitamin K deficiency bleeding with oral mixed micellar phylloquinone: results of a 6-year surveillance in Switzerland. Eur J Pediatr 2003; 162: 885-8.
78. Von Kries R, Heinrich B, Hermann M. [German paediatric surveillance unit (ESPED)]. Monatsschr Kinderheilkd 2002; 149: 1191-7.
79. Von Kries R, Hachmeister A, Göbel U. Oral mixed micellar vitamin K for prevention of late vitamin K deficiency bleeding. Arch Dis Child Fetal Neonatal Ed 2003; 88: F109-12.
80. Laubscher B, Bänziger O, Schubiger G, et al. Prevention of vitamin K deficiency bleeding with three oral mixed micellar phylloquinone doses: results of a 6-year (2005-2011) surveillance in Switzerland. Eur J Pediatr 2013; 172: 357-60.
81. Pediatric Formulary Committee. Vitamin K. In: Pediatric Formulary Commitee, ed. BNF for Children. London: Pharmaceutical Press and PCPCH Publications; 2013; Chapter 9.96: 486-7.
82. Pediatric Formulary Committee. BNF for Children (online). London: BMJ Group, Pharmaceutical Press, and PCPCH Publications 2014
83. McCandlish R, Adams C, Barry C, et al. Routine postnatal care of women and their babies. NICE clinical guideline 37. 2006. http://www.nice.org.uk/guidance/cg37/evidence/cg37-postnatal-care-fullguideline3. Accessed February 7, 2015.
84. De Winter JP, Joosten KF, Ijland MM, et al. New Dutch practice guideline for administration of vitamin K to full-term newborns. Ned Tijdschr Geneeskd 2011; 155: A936.
85. Ijland MM, Pereira RR, Cornelissen EA. Incidence of late vitamin K deficiency bleeding in newborns in the Netherlands in 2005: evaluation of the current guideline. Eur J Pediatr 2008; 167: 165-9.
86. Krag E, Skak-Iversen L. Communication of May the 23rd 2000 on the amended guidelines on the use of Vitamin K in newborn infants and infants for birthplaces, midwives, health visitors and general practitioners. Danish National Board of Health, 2010. http://sundhedsstyrelsen. dk/publ/Off-Medd/officiel-meddelelse-k-vitamin1.pdf. Accessed February 7, 2015.
87. Gotrik JK, Smith E. Health guidance on healthcare related vitamin and iron supplements in newborn infants and infants. Danish National Board of Health, 2010. http://sundhedsstyrelsen.dk/publ/publ2010/cff/jern/vejledning-jern-og-vitaminer.pdf. Accessed February 7, 2015.
88. Hansen KN, Minousis M, Ebbesen F. Weekly oral vitamin K prophylaxis in Denmark. Acta Paediatr 2003; 92: 802-5.
89. Hansen KN, Ebbesen F. Neonatal vitamin K prophylaxis in Denmark: three years? experience with oral administration during the first three months of life compared with one oral administration at birth. Acta Paediatr 1996; 85: 1137-9.
90. Pereira SP, Shearer MJ, Williams R, et al. Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding. Arch Dis Child Fetal Neonatal Ed 2003; 88: F113-8.
91. Cornelissen EA, Kollee LA, van Lith TG, et al. Evaluation of a daily dose of 25 micrograms vitamin K1 to prevent vitamin K deficiency in breast-fed infants. J Pediatr Gastroenterol Nutr 1993; 16: 301-5.
92. Van Hasselt PM, De Koning TJ, Kvist N, et al. Prevention of vitamin K deficiency bleeding in breastfed infants: lessons from the Dutch and Danish biliary atresia registries. Pediatrics 2008; 121: e857-63.
93. Amedee-Manesme O, Lambert WE, Alagille D, et al. Pharmacokinetics and safety of a new solution of vitamin K1(20) in children with cholestasis. J Pediatr Gastroenterol Nutr 1992; 14: 160-5.
94. Harrington DJ, Clarke P, Card DJ, et al. Urinary excretion of vitamin K metabolites in term and preterm infants: relationship to vitamin K status and prophylaxis. Pediatr Res 2010; 68: 508-12.
95. Busfield A, McNinch A, Tripp J. Neonatal vitamin K prophylaxis in Great Britain and Ireland: the impact of perceived risk and product licensing on effectiveness. Arch Dis Child 2007; 92: 754-8.
96. Centers for Disease Control and Prevention. Notes from the field: late vitamin K deficiency bleeding in infants whose parents declined vitamin K prophylaxis-Tennessee, 2003. MMWR Morb Mortal Wkly Rep 2013; 62: 901-2.
97. Schulte R, Jordan LC, Morad A, et al. Rise in late onset vitamin K deficiency bleeding in young infants because of omission or refusal of prophylaxis at birth. Pediatr Neurol 2014; 50: 564-8.
98. Hamrick HJ, Gable EK, Freeman EH, et al. Reasons for refusal of newborn vitamin K prophylaxis: implications for management and education. Hosp Pediatr 2016; 6: 15-21.